Childhood myopia can be slowed significantly with treatments that range from specialty eyewear to eye drops to simple lifestyle changes. None of these options reverse myopia that has already developed, but they can reduce how much worse it gets, and that matters more than many parents realize. The higher a child’s prescription climbs, the greater their lifetime risk of serious eye conditions like retinal detachment, glaucoma, and cataracts. Starting treatment early and combining approaches gives your child the best chance of keeping their prescription as low as possible.
Why Slowing Myopia Matters
Myopia isn’t just an inconvenience that glasses or contacts fix. Every additional increase in prescription stretches the eyeball further, and that physical stretching damages internal structures over time. People who reach high myopia (roughly -5.00 diopters or beyond) face dramatically elevated risks: they’re over 20 times more likely to experience a retinal detachment compared to someone without myopia, nearly 3.5 times more likely to need cataract surgery, and about 2.5 times more likely to develop glaucoma. These aren’t problems that appear in childhood, but they’re shaped by what happens during childhood, when myopia progresses fastest.
Myopia typically starts between ages 6 and 12, progresses most rapidly around age 12, and stabilizes for about half of children by age 15. By age 18, roughly 77% have stabilized, and by 21, about 90%. That window of active progression is when treatment has the most impact.
Spotting Risk Before It Starts
Eye care professionals can identify children at risk of myopia before it actually develops. The International Myopia Institute recommends comparing a child’s farsightedness to what’s normal for their age. A 6-year-old, for example, should have about +0.75 diopters of farsightedness in reserve. A 9- or 10-year-old should have at least +0.25. Children who have less farsightedness than expected for their age are on a trajectory toward myopia, sometimes years before their vision actually blurs. If your child has a family history of myopia or spends heavy amounts of time on screens and books, earlier screening helps catch this shift.
Outdoor Time: The Simplest Protection
Time spent outside is one of the most consistent protective factors against myopia. Research across multiple large reviews shows that each additional hour a child spends outdoors per week reduces their odds of developing myopia by 2% to 5%. The benefit comes from exposure to bright natural light, not from physical activity itself, so even reading outside counts. Most guidelines suggest a minimum of one hour of outdoor recess daily during school, though more is better. For children already diagnosed with myopia, outdoor time alone won’t replace clinical treatment, but it remains a valuable layer of protection.
Rethinking Screen and Reading Habits
Prolonged close-up work, whether reading, drawing, or using devices, is a well-established driver of myopia progression. You’ve probably heard of the 20-20-20 rule: every 20 minutes, look at something 20 feet away for 20 seconds. It’s widely recommended, but newer research from animal models suggests those 20-second micro-breaks may not be long enough to counteract the eye’s growth signals. Sustained breaks of at least 5 minutes every hour appear to be more effective. Keeping books and screens at arm’s length rather than close to the face also helps reduce the strain that promotes eye elongation.
Low-Dose Atropine Eye Drops
Atropine drops are one of the most studied treatments for slowing myopia in children. At very low concentrations, they slow the progression of the eyeball’s lengthening with minimal side effects. A network analysis of multiple trials in Asian children found that 0.05% atropine was the most effective concentration, slowing progression by an average of 0.62 diopters per year compared to placebo. Lower concentrations like 0.01% and 0.025% also worked, slowing progression by 0.31 and 0.43 diopters per year respectively, though with smaller effects.
The drops are applied once daily at bedtime. Higher concentrations are more effective but can cause light sensitivity and difficulty focusing up close because they dilate the pupil and relax the eye’s focusing muscle. At the 0.05% and lower concentrations, these side effects are generally mild. Your child’s eye doctor will typically start with a lower dose and adjust based on how the myopia responds over the following months.
Orthokeratology (Ortho-K) Lenses
Ortho-K involves wearing rigid gas-permeable contact lenses overnight that gently reshape the front surface of the eye while your child sleeps. In the morning, the lenses come out and the child sees clearly all day without glasses or contacts. Beyond the convenience factor, Ortho-K lenses create a specific optical effect: they flatten the center of the cornea while steepening the edges, which shifts how light focuses on the peripheral retina. This peripheral signal appears to slow the eye’s growth.
Studies consistently show Ortho-K slows the lengthening of the eye by 40% to 60% compared to standard glasses, with some studies reporting even greater effects. The reshaping is fully reversible: if your child stops wearing the lenses, the cornea returns to its original shape within days to weeks. The main considerations are that children need to be responsible enough to handle contact lens hygiene, and there’s a small but real risk of eye infection with any overnight contact lens wear. Most practitioners start Ortho-K around age 8 or older.
Myopia-Control Contact Lenses
Soft daily-disposable contact lenses designed for myopia control are another option, and they’re the most convenient contact lens approach since there’s no overnight wear and no cleaning required. The most studied design uses a dual-focus optic that corrects central vision while simultaneously creating a defocus signal in the peripheral retina to slow eye growth.
A six-year clinical trial found that children wearing these lenses accumulated 0.52 mm less eye growth than predicted for untreated children over the full study period, and their growth stayed close to what would be expected in a child without myopia at all. Treatment slowed progression enough that treated eyes took nearly four years longer to reach the same amount of growth that untreated eyes reached, effectively buying the child time during the critical years of fastest progression. These lenses are typically suitable for children as young as 8 who are comfortable with the idea of putting in and removing contacts daily.
Specialty Spectacle Lenses
For children who aren’t ready for contacts or eye drops, specialty glasses lenses offer a non-invasive treatment option. Two main designs dominate the market. Both use arrays of tiny optical elements embedded in otherwise normal-looking lenses to create the same type of peripheral defocus signal that slows eye growth.
A real-world comparison study found that all myopia-control spectacle lenses significantly outperformed standard single-vision glasses. Children wearing standard lenses saw their eyes grow by about 0.19 mm per year, while those wearing the two leading designs averaged 0.098 mm and 0.054 mm per year. For prescription changes, standard glasses wearers progressed by -0.37 diopters per year, while children in specialty lenses progressed by only -0.07 to -0.11 diopters per year. These lenses look and feel like regular glasses, making them the easiest treatment for younger children or those reluctant to use drops or contacts.
Red Light Therapy
A newer approach uses a desktop device that emits low-level red light at a specific wavelength. Children look into the device for 3 minutes per session, twice daily with at least 4 hours between sessions, 5 days per week. A randomized controlled trial of 264 children aged 8 to 13 found that after one year, eye growth in the red light group was 0.13 mm compared to 0.38 mm in the control group, a reduction of about two-thirds. No serious adverse events, vision loss, or structural damage to the retina were observed during the study period.
While these results are promising, red light therapy is newer than the other options and has less long-term safety data. It’s available in some countries but not universally approved, so availability depends on where you live. It may work best as an add-on to other treatments rather than a standalone approach.
Combining Treatments
Many eye care practitioners now layer treatments together, for example pairing low-dose atropine drops with Ortho-K lenses, or combining specialty spectacles with outdoor time goals. The logic is straightforward: each treatment targets eye growth through a slightly different mechanism, and the effects can stack. A child who responds only partially to one treatment may benefit from adding a second. Your child’s eye doctor will typically reassess every 6 to 12 months and adjust the plan based on how fast the eyes are still growing, measured by tracking the axial length of the eye with a quick, painless scan.
Treatment generally continues through the years of active growth. Since about half of children stabilize by age 15 and most by 18 to 21, the decision to stop treatment is usually based on repeated measurements showing that eye growth has plateaued. Stopping too early risks a rebound in progression, so this decision is best guided by objective measurements rather than a fixed age cutoff.